← Open Payments lookup

NNEDINMA AHUKANNA: Open Payments

NPI 1174305445 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$942 in 34 payments from 11 companies in 2025. Trend: 2023 $26 · 2024 $403 · 2025 $942

Food & beverage: $942
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc7$240
Calliditas Therapeutics US Inc.5$155
Otsuka America Pharmaceutical, Inc.6$127
Ardelyx, Inc.1$125
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$92
ABBVIE INC.4$69
E.R. Squibb & Sons, L.L.C.2$37
Vanda Pharmaceuticals Inc.2$29
Alkermes, Inc.1$24
Neurocrine BioSciences, Inc.1$24

Products named: INVEGA SUSTENNA, TARPEYO, XPHOZAH 30 MG, CAPLYTA, VRAYLAR, ABILIFY ASIMTUFII, ABILIFY MAINTENA, COBENFY.

Industry payments across PA — which companies pay providers there.